-
YAZ And Yasmin May Have Higher Risk Of Venous Thrombosis Than Older Birth Control Pills
Recent Studies Find That New Progestin Drospirenone Has 1.7 Times Increased Risk Of Developing Blood Clots Compared To Levonorgestrel (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: "Bayer Affirms Safety Of YAZ / Yasmin…
-
A Theory Of How Yasmin Or YAZ Might Cause Pulmonary Embolism (PE) And Other Blood Clot Related Side Effects
Combination Of Ethinylestradiol And Drospirenone Increases Serum Copper, A Situation That Could Be Associated With Increased Cardiovascular Risk (Posted by Tom Lamb at DrugInjuryWatch.com) In the August 1, 2009 edition of the medical journal…
-
WebMD List Of Symptoms For Serious Side Effects From Using Estrogen-Progestin Birth Control Methods
Important Safety Information For Women Who Are Currently Using YAZ / Yasmin / Ocella, NuvaRing, Or Ortho Evra For Contraception Or Hormone Replacement Therapy (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________________ UPDATE: Our Focus Page…
-
What Are Medication Errors And How Do These Medical Mistakes Tend To Happen
North Carolina State Board Leads Way As Regards Reporting Of Pharmacy-Associated Medication Mistakes (Posted by Tom Lamb at DrugInjuryWatch.com) QJM is a long-established, leading general medical journal. It focuses on internal medicine and publishes…
-
Some Criteria To Determine A New Drug’s Potential For Causing Severe Drug-Induced Liver Injury (DILI)
In July 2009 FDA Issues Updated Guidance For Industry Document Concerning DILI In Premarketing Clinical Evaluation (Posted by Tom Lamb at DrugInjuryWatch.com) In July 2009 the FDA issued a Guidance for Industry document intended for pharmaceutical…
-
Diabetes Drug Avandia Associated With Liver Injury And Liver Failure, Again
July 2009 Medical Journal Article Follows 2008 Public Citizen's Petition For FDA To Ban Sales Of Avandia In U.S. (Posted by Tom Lamb at DrugInjuryWatch.com) In October 2008 Public Citizen petitioned the FDA to…